SSRI antidepressants are linked to lower bone density and a higher fracture risk in many studies. But the evidence is observational, so it shows an association, not proof that the drug caused the loss. If you take an SSRI and have osteopenia or osteoporosis, the sensible response is closer monitoring with your prescriber. It is not stopping the medication on your own.
This guide covers what the largest reviews found, why the link may exist, why the data are hard to read, and the practical steps worth taking.
TL;DR
- Several meta-analyses link SSRI use to lower bone mineral density (BMD) and more fractures, but they cannot separate the drug from depression, inactivity, falls and other factors.
- The link is strongest for recent users and older adults. It does not mean every SSRI user will lose bone.
- Do not stop or cut an SSRI abruptly. Ask your prescriber to review your DXA results, fall risk and the rest of your medications.
- Calcium, vitamin D, supervised exercise and fall prevention remain the foundation of bone care, alongside prescribed osteoporosis treatment when it is indicated.
Table of Contents
- What the large studies found
- Why SSRIs might affect bone
- Why the evidence is hard to read
- What to do if you take an SSRI and have low bone density
- Our perspective
- Where weekly osteogenic loading fits
- Special situations
- FAQ
- Sources
What the large studies found
Researchers have studied this question for almost two decades. The results point in the same direction, with real differences in the details.
| Study | What it analyzed | Main finding |
|---|---|---|
| 2024 meta-analysis | 14 studies, 1,417,134 participants, newer antidepressants | Small but significant BMD differences at several sites; hip-fracture odds of 2.50 (95% CI 2.26–2.76) versus nonuse |
| 2018 meta-analysis | 11 studies of SSRI use and BMD | Lower lumbar-spine BMD (SMD −0.40) and Z-scores, especially in older people; no significant difference at total hip or femoral neck |
| 2021 Korean cohort | 55,799 people with new osteoporosis or osteopenia and 278,995 matched controls | Recent users had higher odds of low bone density: OR 1.35 in men, OR 1.38 in women |
| Fracture review in older adults | SSRI and SNRI use and fractures | 1.67-fold fracture risk with SSRIs (95% CI 1.56–1.79); not enough evidence for a comparable conclusion on SNRIs |
A few details matter when you read these numbers.
The average BMD differences in the 2024 analysis are small. The pooled standardized differences ranged from −0.02 at the total hip to −0.04 at the femoral neck. The fracture signal looks bigger than the density signal. That fits what many clinicians suspect: bone density is only part of the story, and falls may play a role.
The reviews also disagree on location. The 2018 analysis found the lumbar spine affected but not the hip, while the 2024 work reported associations at several sites. A single scan site is not proof for or against an effect in your own case.
In the Korean study, former users had much smaller associations (OR 1.10 in men, 1.07 in women) than recent users. That supports paying attention to bone health during current use. It does not define a safe stopping point.
The fracture review also estimated absolute risks of 2.9% within one year and 13.4% within five years. Those figures come from the observational studies it included, so please don’t read them as your personal risk.
Why SSRIs might affect bone
Serotonin is not only a brain chemical. Researchers have found serotonin receptors and transporters in bone-related cells, which means altered serotonin signaling could plausibly change how bone is broken down and rebuilt by osteoclasts and osteoblasts.
There are also indirect routes. The same review points to falls, sedation, changes in appetite or activity, and factors tied to the illness itself. Someone who is depressed may move less, eat less, smoke or drink more, and take other medications. All of these can affect bone.
That is why the biology is called plausible, not proven. It strengthens the association without telling us how big the risk is for a specific SSRI or a specific person. Nor does it show that switching or stopping an SSRI would reverse bone loss.
Why the evidence is hard to read
Nearly all of this research is observational. People are not randomly assigned to take an SSRI or not, and the people who take one differ in many ways from those who don’t. The 2024 authors note conflicting findings and heterogeneity across studies.
In practice that means:
- Depression itself is a risk factor for osteoporosis. Separating the illness from the treatment is very hard.
- Dose, duration and the specific drug differ between studies.
- Older adults have more falls, more medications and lower baseline bone density, so any effect is amplified in them.
The most defensible reading is risk management. Pay closer attention to bone in recent SSRI users and in anyone already at high fracture risk. Do not treat the drug as automatically unsafe.
What to do if you take an SSRI and have low bone density
Do not stop the medication on your own
Untreated depression and anxiety carry their own serious risks. MedlinePlus says sertraline should not be stopped suddenly because withdrawal symptoms can occur. It also warns that the drug can increase suicidal thoughts or actions in children, teenagers and young adults under 24, particularly in the first months or after dose increases. Bone concerns are not a reason to self-manage a dose.
If you want a medication review but your current clinician is hard to reach, some services offer video consultations in psychiatry and endocrinology, such as online medical consultations. Whoever you see, any change to an antidepressant should be supervised by the clinician who prescribes it.
Bring the right information to your appointment
SSRIs appear on the list of medications to consider when a clinician looks for secondary causes of bone loss, according to the BHOF osteoporosis order set. Make the visit productive by bringing:
- The exact SSRI name, dose, start date and any dose changes or stop dates.
- Prior DXA reports, so trends can be compared.
- Any fracture history, including height loss or sudden back pain.
- A record of falls or near-falls.
- Your calcium and vitamin D intake, smoking and alcohol history.
- Your full medication list, including proton pump inhibitors, steroids and diuretics.
Then ask three questions. Should my DXA or vertebral-fracture assessment be reviewed sooner? Do I have other risk factors that change the picture? Is an osteoporosis medication appropriate for me?
Cover the basics of bone health
BHOF materials list a calcium total of 1,000 mg a day for women 50 and younger and men 70 and younger, and 1,200 mg a day for women 51 and older and men 71 and older. Vitamin D guidance is 400–800 IU a day under age 50 and 800–1,000 IU a day from age 50. These are general targets, not prescriptions. Kidney disease, kidney stones, malabsorption and other conditions change the advice, so check with your clinician before supplementing.
Reduce your chance of falling
The fracture signal in SSRI studies may be partly about falls. Some antidepressants cause dizziness or sedation, so fall prevention deserves real attention. Our guides on fall and fracture risk in osteoporosis and balance training for seniors cover home safety and practical exercises.
Keep your bones loaded, safely
Bone responds to mechanical stress. The right movement matters, though, especially if you already have osteoporosis. Start with our osteoporosis exercise guidelines and see which movements to skip in exercises to avoid with osteoporosis.
Our perspective
People reach us after reading a headline that says their antidepressant is damaging their bones. They are often frightened, and some are tempted to quit the drug. We think that is the wrong first move.
What we see in the research is a reason to be attentive, not alarmed. The association is real across many studies, and the mechanism is plausible. But the studies cannot isolate the drug from the conditions it treats, and the numbers are modest for most people. Your prescriber is the right person to weigh your mood, your bone density and your fracture history together.
Our role is narrower. We offer a non-pharmaceutical, supervised session once a week that uses osteogenic loading to put controlled stress on the skeleton. We see it as a complement to medical evaluation and indicated treatment, never a replacement. BHOF’s own framing is that proven management includes prescribed medication when indicated, adequate calcium and vitamin D, exercise and fall prevention. We agree with that, and we want clients to hear it from us first.
If you take an SSRI, keep your DXA schedule, tell every clinician what you take, and do not let a bone scare push you into abrupt changes.
— Aaron
Where weekly osteogenic loading fits
If you have osteopenia or osteoporosis and your doctor has cleared you for exercise, a supervised program can add structure to your bone care. At our centers in Rancho Cordova, El Dorado Hills and Granite Bay, members come once a week for a brief osteogenic loading session on specialized equipment, with staff present throughout.
You can read how we think about the evidence in osteogenic loading evidence: what patients should know, or see the weekly loading approach for osteoporosis. When you are ready to ask about a session, start at our Osteogenic Loading page. Tell us which medications you take, including your SSRI, so we can work alongside your care team.
We do not publish a price for loading on the site, so please contact the center for current membership details.
Special situations
Teens and young adults
Bone density is a lesser worry than psychiatric safety here. MedlinePlus advises that, for adolescents, antidepressants can take 4–8 weeks or longer for full effect, and that suicidal thinking, worsening anxiety, irritability, impulsivity or sleep changes need prompt attention from the prescriber. Suicidal thoughts in a young person call for urgent help. In the US, call or text 988, the Suicide and Crisis Lifeline.
Early side effects that are not about bone
Two questions people often ask alongside this one: sertraline can cause or worsen anxiety, agitation, restlessness or insomnia early in treatment, and escitalopram (Lexapro) can cause activation-like symptoms such as agitation, irritability, insomnia or unusually high energy. Report these to the prescriber promptly. They are a reason to call, not to quit alone.
People with a prior fracture
If you have already had a fragility fracture, an SSRI is one of several factors your clinician should weigh. Fracture prevention is about proportion: osteoporosis is silent, and fractures carry major consequences. A fracture history strengthens the case for a formal bone evaluation.
FAQ
Do all SSRIs cause bone loss?
The research does not show that every SSRI affects every person. Studies group the drugs together or compare them unevenly, and the effect sizes are small on average. Differences between individual SSRIs are not firmly established, so ask your prescriber about your specific medication.
Should I stop my SSRI if I have osteoporosis?
Not without medical guidance. The evidence cannot show that stopping would restore bone, and abrupt discontinuation can cause withdrawal symptoms and a relapse of depression or anxiety. Your prescriber can weigh the benefits for your mental health against your bone risk.
Is the SSRI osteoporosis risk the same for older adults and younger people?
The signal is clearest in older adults. The 2018 analysis found the lumbar-spine association was particularly evident among older people, and the fracture review focused on adults 50 and over. Younger adults have been studied less, so a firm conclusion is harder.
Can exercise offset the effect of an SSRI on bone?
No study has shown that it cancels any medication effect. Exercise is still a proven part of bone care, along with calcium, vitamin D and fall prevention. Choose a program suited to your bone density, and check with your clinician first.
Sources
- Osteoporosis and Fracture Risk Associated with Novel Antidepressants: A Systematic Review and Meta-Analysis (2024)
- Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis
- Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide cohort study
- SSRI and SNRI use and risk of fractures in adults: a systematic review and meta-analysis
- Serotonin reuptake inhibitors and bone health: a review of clinical studies and plausible mechanisms
- BHOF osteoporosis order set
- BHOF: medication and osteoporosis treatment adherence
- Sertraline: MedlinePlus Drug Information